Log in to save to my catalogue

Insulin Resistance in Long COVID-19 Syndrome

Insulin Resistance in Long COVID-19 Syndrome

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11433386

Insulin Resistance in Long COVID-19 Syndrome

About this item

Full title

Insulin Resistance in Long COVID-19 Syndrome

Publisher

Switzerland: MDPI AG

Journal title

Journal of personalized medicine, 2024-08, Vol.14 (9), p.911

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Background: The COVID-19 pandemic has caused severe health issues worldwide and contributed to huge financial losses. Key comorbidities linked to an increased risk of severe COVID-19 and higher mortality rates include cardio-metabolic disorders such as type 1 and type 2 diabetes mellitus (T1DM and T2DM), atherosclerotic cardiovascular disease, chro...

Alternative Titles

Full title

Insulin Resistance in Long COVID-19 Syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11433386

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11433386

Other Identifiers

ISSN

2075-4426

E-ISSN

2075-4426

DOI

10.3390/jpm14090911

How to access this item